Steven Williamson
Directeur Général chez PULMONX CORPORATION
Fortune : 3 M $ au 31/05/2024
Profil
Steven S.
Williamson is currently the President, Chief Executive Officer & Director at Pulmonx Corp.
since 2024 and the President at Bard Peripheral Vascular, Inc. since 2012.
Previously, he held positions such as Chief Executive Officer at FlowCardia, Inc., President & Director at SenoRx, Inc., and Co-Managing Director at Angiomed GmbH & Co. Medizintechnik KG.
From 2012 to 2017, he served as the President-Peripheral Vascular at C.
R.
Bard, Inc. (New Jersey).
He was also the President-Peripheral Intervention at Becton, Dickinson & Co. from 2018 to 2020.
Prior to that, he worked as the Senior Vice President & General Manager at Hologic, Inc. from 2009 to 2012.
He has also held positions at Cytyc Corp.
and CYTYC Surgical Products.
Mr. Williamson's education includes an MBA from Bentley University and an undergraduate degree from the University of Massachusetts.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PULMONX CORP.
0,53% | 15/03/2024 | 205 286 ( 0,53% ) | 1 M $ | 31/05/2024 |
OUTSET MEDICAL, INC.
0,62% | 15/02/2024 | 320 347 ( 0,62% ) | 1 M $ | 31/05/2024 |
Postes actifs de Steven Williamson
| Sociétés | Poste | Début |
|---|---|---|
| PULMONX CORPORATION | Directeur Général | 15/03/2024 |
Bard Peripheral Vascular, Inc.
 Bard Peripheral Vascular, Inc. Medical SpecialtiesHealth Technology Part of Becton, Dickinson & Co., Bard Peripheral Vascular, Inc. provides surgical and interventional devices for peripheral vascular patency. The company is based in Tempe, AZ. | President | 20/11/2012 |
Anciens postes connus de Steven Williamson
| Sociétés | Poste | Fin |
|---|---|---|
| OUTSET MEDICAL, INC. | Corporate Officer/Principal | 01/03/2024 |
| BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | 01/11/2020 |
| C.R. BARD | Corporate Officer/Principal | 01/12/2017 |
| HOLOGIC, INC. | Corporate Officer/Principal | 01/08/2012 |
Cytyc Corp.
 Cytyc Corp. Medical SpecialtiesHealth Technology Cytyc Corp. manufactures and markets medical diagnostic applications. The company is headquartered in Marlborough, MA. | Sales & Marketing | 22/10/2007 |
Formation de Steven Williamson
| Bentley University | Masters Business Admin |
| University of Massachusetts | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| HOLOGIC, INC. | Health Technology |
| OUTSET MEDICAL, INC. | Health Technology |
| BECTON, DICKINSON AND COMPANY | Health Technology |
| PULMONX CORPORATION | Health Technology |
| Entreprise privées | 7 |
|---|---|
CYTYC Surgical Products
 CYTYC Surgical Products Pharmaceuticals: MajorHealth Technology CYTYC Surgical Products was founded to design, develop, manufacture and market innovative therapeutic devices that improve the quality of women's healthcare in a cost- effective manner. Its initial product, the Novasure Endometrial Ablation System, is used to treat women who suffer from excessive menstrual bleeding. | Health Technology |
Cytyc Corp.
Cytyc Corp. Medical SpecialtiesHealth Technology Cytyc Corp. manufactures and markets medical diagnostic applications. The company is headquartered in Marlborough, MA. | Health Technology |
Bard Peripheral Vascular, Inc.
Bard Peripheral Vascular, Inc. Medical SpecialtiesHealth Technology Part of Becton, Dickinson & Co., Bard Peripheral Vascular, Inc. provides surgical and interventional devices for peripheral vascular patency. The company is based in Tempe, AZ. | Health Technology |
SenoRx, Inc.
 SenoRx, Inc. Medical SpecialtiesHealth Technology SenoRx, Inc. develops and manufactures invasive devices for the diagnosis and treatment of breast cancer. The company was founded in 1998 and is headquartered in Tempe, AZ. | Health Technology |
FlowCardia, Inc.
 FlowCardia, Inc. Medical SpecialtiesHealth Technology FlowCardia, Inc. designs, develops and manufactures endovascular devices. It offers flowmate Injector to optimize the performance of crosser cto recanalization and crosser catheter, a minimally-invasive endovascular device. The firm also provides portfolio of catheter-based technologies to facilitate guidewire crossing of totally occluded coronary and peripheral arteries. The company was founded by Henry Nita and Erik T. Engelson in 2001 and is headquartered in Sunnyvale, CA. | Health Technology |
Angiomed GmbH & Co. Medizintechnik KG
 Angiomed GmbH & Co. Medizintechnik KG Aerospace & DefenseElectronic Technology Angiomed GmbH & Co. Medizintechnik KG manufactures electrical measuring, control and navigation instruments. The company is headquartered in Karlsruhe, Germany. | Electronic Technology |
C. R. Bard, Inc. (New Jersey)
 C. R. Bard, Inc. (New Jersey) Medical SpecialtiesHealth Technology C. R. Bard, Inc. engages in designing, development, manufacturing, packaging, distribution, and sales of medical, surgical, diagnostic, and patient care devices. It sells its products to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities. The company was founded by Charles Russell Bard in 1907 and is headquartered in Franklin Lakes, NJ. | Health Technology |
